- Home
- RSLS vs HSCS Comparison
RSLS vs HSCS Comparison
Compare RSLS & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- HSCS
- Stock Information
- Founded
- RSLS 2002
- HSCS 2007
- Country
- RSLS United States
- HSCS United States
- Employees
- RSLS N/A
- HSCS N/A
- Industry
- RSLS Medical/Dental Instruments
- HSCS Medical Specialities
- Sector
- RSLS Health Care
- HSCS Health Care
- Exchange
- RSLS Nasdaq
- HSCS Nasdaq
- Market Cap
- RSLS 3.2M
- HSCS 2.8M
- IPO Year
- RSLS 2007
- HSCS 2022
- Fundamental
- Price
- RSLS $0.64
- HSCS $3.05
- Analyst Decision
- RSLS Hold
- HSCS Strong Buy
- Analyst Count
- RSLS 1
- HSCS 2
- Target Price
- RSLS N/A
- HSCS $13.50
- AVG Volume (30 Days)
- RSLS 3.3M
- HSCS 18.8K
- Earning Date
- RSLS 03-31-2025
- HSCS 03-25-2025
- Dividend Yield
- RSLS N/A
- HSCS N/A
- EPS Growth
- RSLS N/A
- HSCS N/A
- EPS
- RSLS N/A
- HSCS N/A
- Revenue
- RSLS $8,183,000.00
- HSCS $14,700.00
- Revenue This Year
- RSLS $17.47
- HSCS $174.19
- Revenue Next Year
- RSLS $20.00
- HSCS $4,100.00
- P/E Ratio
- RSLS N/A
- HSCS N/A
- Revenue Growth
- RSLS N/A
- HSCS 151.28
- 52 Week Low
- RSLS $0.63
- HSCS $2.36
- 52 Week High
- RSLS $29.00
- HSCS $13.50
- Technical
- Relative Strength Index (RSI)
- RSLS 19.59
- HSCS 40.90
- Support Level
- RSLS $0.63
- HSCS $2.72
- Resistance Level
- RSLS $1.28
- HSCS $3.58
- Average True Range (ATR)
- RSLS 0.15
- HSCS 0.35
- MACD
- RSLS 0.05
- HSCS -0.06
- Stochastic Oscillator
- RSLS 1.15
- HSCS 33.92
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.